Sung Il Jung1, Hae Jeong Jeon1, Hee Sun Park1, Mi Hye Yu1, Young Jun Kim1, Seung Eun Lee2, So Dug Lim2. 1. 1 Department of Radiology, Konkuk University Medical Center, Research Institute of Medical Science, Konkuk University School of Medicine , Seoul , Korea. 2. 2 Department of Pathology, Konkuk University Medical Center, Konkuk University School of Medicine , Seoul , Korea.
Abstract
OBJECTIVE: To evaluate effect of postbiopsy hemorrhage on detection of peripheral zone (PZ) prostate cancer by multiparametric MR imaging according to Gleason score and tumor volume. METHODS: This retrospective study included 54 biopsy-proven prostate cancer patients (median age, 67.0 years) who underwent multiparametric MR imaging. Two independent readers evaluated each sextant of the PZ using the PI-RADS v2. One reader recorded the presence or absence of hemorrhage per sextant on T1 weighted MR images. Areas under the receiver operating characteristic curves (AUCs) were used to evaluate cancer detection accuracy. RESULTS: Postbiopsy hemorrhage was noted in 122 (37.7%) of 324 sextants of all patients. There was no significant difference in the AUC for detection of cancer with Gleason score ≥3 + 4 or volume ≥0.5 ml between sextants with and without hemorrhage (with hemorrhage, reader 1, 0.83 for Gleason score ≥3 + 4, 0.84 for tumor volume ≥0.5 ml; reader 2, 0.74 for Gleason score ≥3 + 4, 0.77 for tumor volume ≥0.5 ml; without hemorrhage, reader 1, 0.86 for Gleason score ≥3 + 4, 0.88 for tumor volume ≥0.5 ml; reader 2, 0.79 for Gleason score ≥3 + 4, 0.83 for tumor volume ≥0.5 ml; p > 0.2 for all). CONCLUSION: Postbiopsy hemorrhage did not negatively affect the detection of clinically significant PZ prostate cancer on multiparametric MR imaging. Advances in knowledge: Under influence of postbiopsy hemorrhage, multiparametric MR can be useful for the detection of clinically significant PZ prostate cancer.
OBJECTIVE: To evaluate effect of postbiopsy hemorrhage on detection of peripheral zone (PZ) prostate cancer by multiparametric MR imaging according to Gleason score and tumor volume. METHODS: This retrospective study included 54 biopsy-proven prostate cancerpatients (median age, 67.0 years) who underwent multiparametric MR imaging. Two independent readers evaluated each sextant of the PZ using the PI-RADS v2. One reader recorded the presence or absence of hemorrhage per sextant on T1 weighted MR images. Areas under the receiver operating characteristic curves (AUCs) were used to evaluate cancer detection accuracy. RESULTS: Postbiopsy hemorrhage was noted in 122 (37.7%) of 324 sextants of all patients. There was no significant difference in the AUC for detection of cancer with Gleason score ≥3 + 4 or volume ≥0.5 ml between sextants with and without hemorrhage (with hemorrhage, reader 1, 0.83 for Gleason score ≥3 + 4, 0.84 for tumor volume ≥0.5 ml; reader 2, 0.74 for Gleason score ≥3 + 4, 0.77 for tumor volume ≥0.5 ml; without hemorrhage, reader 1, 0.86 for Gleason score ≥3 + 4, 0.88 for tumor volume ≥0.5 ml; reader 2, 0.79 for Gleason score ≥3 + 4, 0.83 for tumor volume ≥0.5 ml; p > 0.2 for all). CONCLUSION: Postbiopsy hemorrhage did not negatively affect the detection of clinically significant PZ prostate cancer on multiparametric MR imaging. Advances in knowledge: Under influence of postbiopsy hemorrhage, multiparametric MR can be useful for the detection of clinically significant PZ prostate cancer.
Authors: Aliya Qayyum; Fergus V Coakley; Ying Lu; Jeffrey D Olpin; Louis Wu; Benjamin M Yeh; Peter R Carroll; John Kurhanewicz Journal: AJR Am J Roentgenol Date: 2004-10 Impact factor: 3.959
Authors: Courtney A Woodfield; Glenn A Tung; David J Grand; John A Pezzullo; Jason T Machan; Joseph F Renzulli Journal: AJR Am J Roentgenol Date: 2010-04 Impact factor: 3.959
Authors: Andrew B Rosenkrantz; Martin Kopec; Xiangtian Kong; Jonathan Melamed; George Dakwar; James S Babb; Bachir Taouli Journal: J Magn Reson Imaging Date: 2010-06 Impact factor: 4.813
Authors: A B Rosenkrantz; T C Mussi; N Hindman; R P Lim; M X Kong; J S Babb; J Melamed; S S Taneja Journal: Clin Radiol Date: 2012-09-13 Impact factor: 2.350